Aviva’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.1M | Sell |
1,431,447
-57,161
| -4% | -$3.1M | 0.09% | 212 |
|
|
2026
Q1 | $93.4M | Buy |
1,488,608
+2,896
| +0.2% | +$232K | 0.16% | 123 |
|
|
2025
Q4 | $142M | Buy |
1,485,712
+311,905
| +27% | +$30.6M | 0.24% | 80 |
|
|
2025
Q3 | $115M | Buy |
1,173,807
+84,108
| +8% | +$8.71M | 0.21% | 97 |
|
|
2025
Q2 | $117M | Buy |
1,089,699
+406,753
| +60% | +$41.2M | 0.24% | 84 |
|
|
2025
Q1 | $68.9M | Buy |
682,946
+132,211
| +24% | +$13.3M | 0.17% | 135 |
|
|
2024
Q4 | $49.2M | Buy |
550,735
+14,577
| +3% | +$1.28M | 0.13% | 175 |
|
|
2024
Q3 | $44.9M | Buy |
536,158
+18,003
| +3% | +$1.42M | 0.12% | 206 |
|
|
2024
Q2 | $39.9M | Buy |
518,155
+113,112
| +28% | +$8.28M | 0.11% | 217 |
|
|
2024
Q1 | $27.7M | Buy |
405,043
+27,670
| +7% | +$1.78M | 0.09% | 266 |
|
|
2023
Q4 | $21.8M | Buy |
377,373
+44,339
| +13% | +$2.37M | 0.08% | 301 |
|
|
2023
Q3 | $17.6M | Sell |
333,034
-21,479
| -6% | -$1.13M | 0.07% | 344 |
|
|
2023
Q2 | $19.2M | Buy |
354,513
+122,033
| +52% | +$6.37M | 0.08% | 316 |
|
|
2023
Q1 | $11.6M | Sell |
232,480
-93,883
| -29% | -$4.42M | 0.05% | 443 |
|
|
2022
Q4 | $15.1M | Sell |
326,363
-107,133
| -25% | -$4.64M | 0.07% | 367 |
|
|
2022
Q3 | $16.8M | Buy |
433,496
+177,821
| +70% | +$7.13M | 0.1% | 295 |
|
|
2022
Q2 | $9.53M | Sell |
255,675
-91,435
| -26% | -$3.72M | 0.05% | 459 |
|
|
2022
Q1 | $15.4M | Sell |
347,110
-97,209
| -22% | -$4.21M | 0.08% | 318 |
|
|
2021
Q4 | $18.9M | Sell |
444,319
-527,842
| -54% | -$22.2M | 0.08% | 244 |
|
|
2021
Q3 | $42.2M | Sell |
972,161
-25,252
| -3% | -$1.12M | 0.19% | 120 |
|
|
2021
Q2 | $42.6M | Sell |
997,413
-16,658
| -2% | -$701K | 0.19% | 117 |
|
|
2021
Q1 | $39.2M | Buy |
1,014,071
+6,822
| +0.7% | +$258K | 0.19% | 117 |
|
|
2020
Q4 | $36.2M | Buy |
1,007,249
+12,297
| +1% | +$443K | 0.19% | 110 |
|
|
2020
Q3 | $38M | Sell |
994,952
-8,921
| -0.9% | -$344K | 0.22% | 93 |
|
|
2020
Q2 | $35.2M | Buy |
1,003,873
+680,778
| +211% | +$24.5M | 0.22% | 94 |
|
|
2020
Q1 | $10.5M | Sell |
323,095
-7,800
| -2% | -$305K | 0.08% | 221 |
|
|
2019
Q4 | $15M | Sell |
330,895
-15,924
| -5% | -$666K | 0.09% | 196 |
|
|
2019
Q3 | $14.1M | Sell |
346,819
-162,551
| -32% | -$6.89M | 0.1% | 196 |
|
|
2019
Q2 | $21.9M | Sell |
509,370
-11,755
| -2% | -$452K | 0.15% | 143 |
|
|
2019
Q1 | $20M | Buy |
521,125
+832
| +0.2% | +$31.8K | 0.13% | 159 |
|
|
2018
Q4 | $18.4M | Sell |
520,293
-148,360
| -22% | -$5.38M | 0.14% | 163 |
|
|
2018
Q3 | $25.7M | Sell |
668,653
-23,892
| -3% | -$834K | 0.14% | 161 |
|
|
2018
Q2 | $22.6M | Sell |
692,545
-5,001
| -0.7% | -$151K | 0.13% | 165 |
|
|
2018
Q1 | $19.1M | Sell |
697,546
-59,759
| -8% | -$1.62M | 0.12% | 190 |
|
|
2017
Q4 | $18.8M | Sell |
757,305
-105,083
| -12% | -$2.9M | 0.11% | 218 |
|
|
2017
Q3 | $25.2M | Buy |
862,388
+9,060
| +1% | +$250K | 0.14% | 174 |
|
|
2017
Q2 | $23.7M | Buy |
853,328
+11,025
| +1% | +$293K | 0.13% | 179 |
|
|
2017
Q1 | $20.9M | Sell |
842,303
-47,562
| -5% | -$1.16M | 0.12% | 190 |
|
|
2016
Q4 | $19.3M | Buy |
889,865
+57,208
| +7% | +$1.25M | 0.12% | 203 |
|
|
2016
Q3 | $19.8M | Buy |
832,657
+21,685
| +3% | +$517K | 0.12% | 199 |
|
|
2016
Q2 | $18.9M | Buy |
810,972
+65,200
| +9% | +$1.41M | 0.13% | 181 |
|
|
2016
Q1 | $14M | Buy |
745,772
+14,370
| +2% | +$252K | 0.1% | 211 |
|
|
2015
Q4 | $13.5M | Sell |
731,402
-5,478
| -0.7% | -$98.2K | 0.1% | 219 |
|
|
2015
Q3 | $12.1M | Sell |
736,880
-13,780
| -2% | -$236K | 0.1% | 226 |
|
|
2015
Q2 | $13.3M | Buy |
750,660
+39,810
| +6% | +$711K | 0.09% | 235 |
|
|
2015
Q1 | $12.6M | Buy |
710,850
+171,628
| +32% | +$2.71M | 0.09% | 263 |
|
|
2014
Q4 | $7.14M | Sell |
539,222
-2,345
| -0.4% | -$30K | 0.06% | 376 |
|
|
2014
Q3 | $6.4M | Sell |
541,567
-1,040
| -0.2% | -$13.1K | 0.05% | 410 |
|
|
2014
Q2 | $6.93M | Sell |
542,607
-3,680
| -0.7% | -$47.9K | 0.05% | 399 |
|
|
2014
Q1 | $7.39M | Sell |
546,287
-192,824
| -26% | -$2.53M | 0.06% | 347 |
|
|
2013
Q4 | $8.88M | Buy |
739,111
+17,102
| +2% | +$202K | 0.07% | 292 |
|
|
2013
Q3 | $8.48M | Sell |
722,009
-212,718
| -23% | -$2.3M | 0.07% | 288 |
|
|
2013
Q2 | $8.66M | Buy |
+934,727
| New | +$7.93M | 0.09% | 252 |
|
Other funds holding BSX
Aviva's BSX Position: Q2 2026 in Review
Aviva reduced its Boston Scientific (BSX) stake by 3.8% in Q2 2026, selling an estimated $3.1M and leaving 1,431,447 shares worth $61.1M. The position accounts for 0.09% of the portfolio, ranked #212.
Aviva first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $142M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Aviva held 1,431,447 shares of Boston Scientific worth $61.1M as of Q2 2026.
- Aviva sold 57,161 Boston Scientific shares in Q2 2026, an estimated $3.1M.
- Boston Scientific made up 0.09% of Aviva's portfolio in Q2 2026, its #212 holding.
- Aviva first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Aviva's Boston Scientific position peaked at $142M in Q4 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.